BSO to host prescription drug disposal, document shredding event
The
Broward Sheriff's Office
is set to host a free community event Saturday aimed at combating prescription drug abuse and identity theft, authorities announced.
Dubbed Operation Medicine Cabinet and Shred-A-Thon, the event will run from 10 a.m. to 1 p.m. at the BSO Oakland Park District, located at 5399 North Dixie Highway.
Sheriff Dr. Gregory Tony and his team are urging residents to participate by bringing unused or expired medications and sensitive documents for safe disposal.
The initiative is part of the sheriff's ongoing efforts to address two pressing issues in Broward County.
Residents who turn in prescription medications will receive a $5 gift card while supplies last, though needles and sharp objects will not be accepted.
For document shredding, participants may bring up to two boxes per vehicle, with each box limited to 16 inches long, 12 inches wide, and 12 inches high.
BSO officials say the event reflects their commitment to public safety by reducing the risk of drug misuse and protecting personal information from falling into the wrong hands.
For more information, the sheriff's office directs the public to call 954-831-8902 or visit sheriff.org.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
World Precision Instruments and SynVivo Launch Next-Generation Multiplexed TEER-on-a-Chip Platform for Real-Time Organ-on-a-Chip Cell Monitoring
SARASOTA, Fla. and HUNTSVILLE, Ala., June 11, 2025 /PRNewswire/ -- World Precision Instruments (WPI), a global leader in transepithelial electrical resistance (TEER) instrumentation, and SynVivo Inc., a pioneer in Organ-on-a-Chip (OOC) technology, today announced the commercial launch of a next-generation multiplexed TEER-on-a-Chip platform—a breakthrough solution enabling real-time, high-throughput measurement of barrier integrity in advanced Organ-on-a-Chip models. The co-developed platform integrates WPI's gold-standard EVOM™ measurement technology with SynVivo's SynTEER™ multiplexed OOC models with embedded electrodes, providing researchers with a seamless solution for performing TEER measurements directly within microfluidic chips. Initially validated on SynVivo's advanced SynBBB™ Blood-Brain Barrier model, this is the first in a planned series of Organ-on-a-Chip platforms powered by the new EVOM-Chip™ system from WPI. With electrodes embedded directly into SynVivo's SynTEER™ multiplexed OOC models researchers can now perform real-time TEER measurements across multiple channels—enabling continuous barrier monitoring, streamlined workflows, and improved reproducibility. The EVOM-Chip™ system allows for hands-free, simultaneous data collection, and remains fully compatible with live-cell imaging and physiologically relevant flow conditions. "This collaboration represents a major advancement in functional barrier modeling," said Gwen Fewell, President & CEO of SynVivo Inc. "Integrating TEER measurement directly into our chip enhances data fidelity, reduces variability, and streamlines experimental workflows—key to enabling more predictive, standardized and scalable in vitro models. By combining our vascularized OOC technology with WPI's industry-leading TEER measurement expertise, we're delivering a powerful solution for researchers tackling complex questions in CNS drug development, inflammation, and drug discovery." WPI's EVOM™ family of TEER instrumentation has set the standard for barrier function assessment for over 30 years. SynVivo's SynTEER™ platform builds on this legacy with pre-integrated, precisely aligned electrodes designed to optimize TEER signal fidelity across a range of Organ-on-a-Chip applications. As the OOC market rapidly grows, it continues to face challenges around standardization and automation, both of which are essential for mainstream adoption in pharmaceutical research. "A critical gap has been the ability to perform on-chip, non-destructive sensing—particularly TEER measurements—a need shared by the majority of OOC platforms but rarely implemented successfully or in a multiplex fashion," explains Mark Rutledge, CEO of WPI. "With EVOM™ Chip, researchers can monitor their OOC platforms from cell seeding through barrier formation, as well as before, during and after drug treatment, to get accurate and reproducible readouts, without affecting the health or well-being of the cells." The system's initial application on the SynBBB™ Blood-Brain Barrier platform has demonstrated a strong correlation between electrical resistance and functional barrier properties, supporting its use in CNS drug development, inflammation studies, and neurovascular research. See It Live at MPS World Summit – Brussels, June 10–13, 2025Visit WPI and SynVivo at the MPS World Summit to explore the EVOM-Chip™ and SynTEER-on-a-Chip systems in action and learn how integrated TEER-on-Chip technology can accelerate your research. WPI Booth #131 SynVivo Booth #404 ABOUT WORLD PRECISION INSTRUMENTS For over 55 years, World Precision Instruments (WPI) has been a leading global manufacturer and provider of innovative research equipment and laboratory supplies to the life sciences, pharmaceutical, health care, and industrial markets. Our proven technology supports complex model development, including preclinical models and organ-on-a-chip systems, providing researchers with the tools to identify and validate drugs to understand mechanism of action, dosage, administration, drug-drug interactions, patient-specific reactions, pharmacokinetics, pharmacodynamics, safety and efficacy. Our areas of innovation focus on tissue and cell biology, fluidics, animal physiology and electrophysiology. With an extensive global network and a passion for innovation, WPI provides novel solutions to customers' daily challenges. For more information, visit About SynVivoSynVivo is a pioneering organ-on-chip company developing physiologically relevant tissue models for drug discovery, disease research, and safety testing. Its advanced microfluidic platforms replicate human tissue microenvironments to enhance the predictive accuracy of in vitro testing. SynVivo is committed to bridging the gap between traditional preclinical models and human clinical outcomes, advancing a new standard in predictive, human-relevant drug development. View original content to download multimedia: SOURCE SynVivo and World Precision Instruments Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Yahoo
Wishes Can't Wait Telethon phone lines are OPEN!
ALABAMA (WHNT) — News 19 and Make-A-Wish Alabama are partnering up for the Wishes Can't Wait telethon TODAY! Phone lines open at 6 a.m. and will close at 7 p.m. To donate by phone, you can call (256) 319-1371. More than 70 children in North Alabama are waiting for Make-A-Wish Alabama to grant their wishes. That's why News 19 is partnering with Make-A-Wish Alabama to help fulfill these wishes, because Wishes Can't Wait! The children who are waiting for their wishes to be granted are all living with a critical illness. Some of those children have spent most of their lives in and out of doctors' offices, hospitals and treatments. Make-A-Wish helps those children live a life outside of their medical complications by offering them a joyful moment amidst an otherwise difficult time. Whether it's meeting a celebrity, asking for a gift, or planning the trip of a lifetime, Make-A-Wish wants to give every child their dream. Those wishes make a big impact. Last year, Make-A-Wish surveyed over 3,000 wish alumni, wish parents and medical professionals about the impact of granted wishes. Here's what they found: Nine out of 10 wish kids reported that the wish experience relieved them from traumatic stress Nine out of 10 wish parents saw their child's emotional well-being improve with a wish Nine out of 10 medical providers say a wish increased compliance with treatment Nine out of 10 medical providers observed that the wish experience has a positive impact on a child's physical well-being and overall quality of life Eight out of 10 wish kids reported that their wish gave them the strength to fight their critical illness. The problem is that wishes are expensive. The average wish costs $10,000, and Make-A-Wish relies on donors to grant every single one. 245 children are waiting throughout Alabama, and 78 of them are in North Alabama. Any of those children could be your neighbors, co-workers' kids, or classmates of your own children. Anyone can donate, including businesses! We encourage business owners in the area to consider Wishes Can't Wait as part of their philanthropy efforts. We know our viewers have a heart for service, and you prove it over and over again. The best part is you know your money is staying right here in the state. 100% of the proceeds go to children in our backyard, fighting these unimaginable medical battles. We are accepting donations right now! If you'd like to donate online, you can donate here. You can also text WISHES to 44834. Make-A-Wish Alabama has granted over 1,700 wishes since the chapter's founding in 2012. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
8 hours ago
- Yahoo
MERGE Continues Growth Trajectory with Strategic Additions to Leadership
CHICAGO, June 11, 2025--(BUSINESS WIRE)--MERGE, a leading marketing and technology agency, announces two strategic hires to strengthen and further accelerate its mission of integrated growth and innovation. Heidi West steps into the role of Chief Revenue Officer, and John Bracey joins MERGE as Chief Data and Performance Officer. These accomplished executives bring decades of experience and expertise, fortifying the agency's leadership team as it continues to expand at the intersection of health and wellness. Heidi West, MERGE's new Chief Revenue Officer, offers over 30 years of exceptional sales leadership and a history of delivering impactful technology solutions across healthcare, including at CommonSpirit Health, Englewood Health, Mount Sinai Health System, Stanford Health Care, and other diverse industries. Most recently leading the healthcare team at Zoom, West has held sales and leadership roles at Cisco, Nutanix, and Booz Allen. "I am incredibly excited to join MERGE at such a pivotal time," said West. "I look forward to leveraging my experience in healthcare and technology to help MERGE bridge the gap between health and consumer verticals. By focusing on improving patient engagement and experience, we can deliver trusted, relatable solutions guided by AI and data-driven strategies for our clients and their audiences." West's background in healthcare and executive engagement, combined with her talent for building high-performing sales teams aligned with strategic goals, makes her an invaluable catalyst for strategic growth. Commenting on this significant leadership addition, Stephanie Trunzo, MERGE CEO, remarked, "While leading Oracle Health, I met Heidi in her role driving the health business at Zoom. Her extensive experience in the health industry, coupled with her strategic sales expertise and sincere approach will catalyze the outcome-oriented momentum of our client service and business development teams." Beyond her professional achievements, West is a passionate advocate for women in technology and STE(A)M initiatives. John Bracey, a visionary in data science and analytics, brings an impressive track record of transforming global brands into organizations driven by insight. Formerly EVP at Publicis Groupe, Bracey spearheaded data-driven transformation initiatives across a number of Publicis Groupe's largest consumer and healthcare brands. "My expertise lies where data science and strategy meet. I'm passionate about helping brands maximize the value of their data and media investments, whether by engineering insight or architecting performance," said Bracey. "Across industries, I've seen that an audience-first approach consistently drives better insights and stronger outcomes. At MERGE, I look forward to continuing this work, turning complex data into automated, actionable solutions that deliver measurable business outcomes." "John's ability to harness data to transform businesses will substantively enhance how we deliver personalized, meaningful solutions that unite people and brands. These data-smart offerings will be the electricity that runs through creative and tech implementations to identify, optimize, and predictively model impact. We're incredibly excited about the amplified innovation he will bring to MERGE," said Trunzo. The West and Bracey appointments further accelerate MERGE's strategic leadership expansion, building on the other significant executive announcements this year beginning with Stephanie Trunzo's announcement as CEO, and including Erica Denner (Chief People Officer), Kyle Smith (CTO), Paul Buranosky (CMO), and Chris Esposito (CFO). About MERGE MERGE is a marketing and technology agency built for the intersection of health and wellness. We combine deep expertise in health and consumer behavior with strategy, creativity, experience technology, and digital marketing to design personalized experiences that drive meaningful results. Powered by human insight, creativity, and AI, we weave storytelling through technology to turn complexity into clarity — strengthening relationships between people and brands. With 750+ specialists across Atlanta, Boston, Chicago, Denver, Kansas City, Los Angeles, New York, and Raleigh, MERGE partners with leading brands like Abbott, GE Healthcare, American Express, T-Mobile, Coach, and Meta to advance health, wellness, and happiness. Learn more at View source version on Contacts Mary Josephmjoseph@
